Open original FDA record ↗Recall record
- FDA identifier
- Z-0384-2019
- Company in FDA record
- Becton Dickinson & Company
- FDA record creation date
- Nov 4, 2018
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
One lot of the specified needles is not performing as intended due to a failure in the needle tip shield/safety mechanism, which may lead to an increased risk of a contaminated needlestick injury.
Source facts
- Action
- Urgent Medical Device Recall notification letters dated 8/23/18 were sent to customers. The letters instruct customers to perform the following actions: 1. Immediately review your inventory for the specific Catalogue (Ref) and lot number listed above and destroy all product subject to the recall following your institutions process for destruction. 2. Share this recall notification with all users of the product to ensure that they are also aware of this recall. 3. Complete the attached Customer Response Form and return to the BD contact noted on the form whether or not you have any of the impacted material so that BD may acknowledge your receipt of this notification and process your product replacement. 4. Report any adverse health consequences experienced with the use of this product to BD. Events may also be reported to the FDA's MedWatch Adverse Event Reporting program. Web: MedWatch website at www.fda.gov/medwatch Phone: 1-800-FDA-1088 (1-800-332-1088) Mail: MedWatch, HF-2, FDA, 5600 Fishers Lane, Rockville, MD 20852-9787 Actions Taken Distributors were instructed to: 1. Immediately review your inventory for the specific Catalogue (Ref) and lot number listed above and return all product subject to recall according to the Packing Instructions enclosed. 2. Identify all your customers that purchased any affected product, as defined in this recall notification. E-mail an excel file listing of all customers to BDMPSRC@bd.com, within 72 hours of receipt of this letter. 3. Complete the attached Wholesaler/Distributor Response Form and return to the BD contact noted on the form whether or not you have any of the impacted material so that BD may acknowledge your receipt of this notification and process your credit accordingly. 4. Report any adverse health consequences experienced with the use of this product to BD. Events may also be reported to the FDA's MedWatch Adverse Event Reporting program. Web: MedWatch website at www.fda.gov/medwatch Phone: 1
- Initiated
- 2018-08-23
- Root cause
- Under Investigation by firm
- Terminated
- 2020-02-28
- Distribution
- Worldwide Distribution -US Nationwide in the states of: CA, CO, FL, GA, IL, LA, MI, ND, NE, NY, OH, PA, RI, SC, VA, WA and WV. The products were distributed to the following foreign countries: Argentina, Australia, Belgium, Brazil, Canada, Colombia, Costa Rica, Mexico and New Zealand.
- Recall number
- Z-0384-2019
- Recall status
- Terminated
- CDRH record ID
- 167336
- FDA record created
- 2018-11-04
- Recall event number
- 81040